Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
About This Webinar

ABL, Inc. is a CDMO and CRO providing GMP manufacturing and immunology solutions for gene therapies, oncolytics, vaccines and other immunotherapeutics. We specialize in immuno-oncology, infectious diseases, neurological diseases and chronic diseases. ABL has a global footprint, with facilities in the U.S. and Europe, offering integrated product development platforms for GMP virus and protein manufacture, bioanalytical services, biomarker identification and immunological testing.  Please visit us at www.ablinc.com and email us at info@ablinc.com to discuss how we can help advance your innovative therapies and vaccines with a revolutionary partnership!

Agenda
  • US Viral Vector Capabilities
  • European Viral Vector Capabilities
  • Global Immunology and Testing Services
Language: English
Who can attend? Anyone with the event link can attend
Featured Presenters
Webinar hosting presenter Rashida Williams
Marketing Specialist
Webinar hosting presenter
Sales Manager, Biomanufacturing
Technical Sales Manager here to help plan your cell and gene therapy manufacturing projects. Let’s discuss a partnership with ABL!
Webinar hosting presenter
Sales Manager, Immunology
Scientist-turned-sales manager. From biomarker detection to cellular assays, I can help you find the right immunology research support for your therapies.
Webinar hosting presenter
VP, Immunology
Immunology guru. My staff of experts and I can support you from the bench to the clinic.
Webinar hosting presenter
Director, Process Development
An ABL leader looking to join forces for a powerful partnership on virus vector development and manufacturing. Lets discuss today how can we bring your innovation to the clinic.
Webinar hosting presenter
Director, Global Strategy and Marketing
Hosted By
ASGCT 23rd Annual Meeting  webinar platform hosts ABL, Inc. Your Global CDMO & CRO Partner
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.